1. 842PCTC-based biomarkers & PSMA-targeted imaging in patients with metastatic castrate-resistant prostate cancer (mCRPC). (23rd October 2018) Authors: Morris, M J; Vogelzang, N J; Sartor, O; Armour, A; Messmann, R; Groaning, M; Robarts, A; Tolcher, A W; Gordon, M; Babiker, H M; Kuo, P; Kearney, M; Jendrisak, A; Wang, Y; Landers, M; Petrylak, D P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗